Lymphoma Clinical Trials

Showing 1441-1460 of 3,379 trials

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

NCT00002520

RATIONALE: Physician-initiated smoking cessation strategies may be effective in getting early-stage cancer patients to quit smoking. PURPOSE: Randomized clinical trial to compare the effectiveness of a physician-initiated stop-smoking program with the usual care for patients receiving treatment for early-stage cancer.

Bladder CancerBreast CancerColorectal Cancer+7 more

Eastern Cooperative Oncology Group434 participantsStarted Dec 1990

Philadelphia, Pennsylvania, United States

TERMINATEDPhase 1

GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma

NCT05242146

The STAR CNS trial is a 3-part study, comprising a phase 1b dose escalation, dose expansion, and a phase 2, to assess the safety, tolerability, dose-limiting toxicity(ies), maximum tolerated dose, and/or optimal biological dose, determine the recommended phase 2 dose, preliminary anti-tumor activity and efficacy of the recommended phase 2 dose of GB5121.

CNS Lymphoma

GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.12 participantsStarted May 2022

Phoenix, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States +13 more locations

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma

Related Searches

Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Efficacy of Lenalidomide Maintenance in Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma: a Phase II, Open-label, Single-arm Study

KN046 in Subjects With Advanced Solid Tumors and Lymphoma

CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies

A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment

Expanded Access Program for Epcoritamab

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study

Efficacy and Safety of Venetoclax Combined With BEAM Pretreatment in Autologous Transplantation for DLBCL

Real World Study of Linperlisib for Lymphoma Treatment

Quality of Life of Adults With Diffuse Large B-cell Lymphoma Treated With Tisagenlecleucel

CAR T Cell Therapy Related Cardiovascular Outcomes

CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies

Information Support Using an Online Learning Platform for Malaysian Pediatric Leukemia and Lymphoma Parents

A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma